Anti-PDCD7 monoclonal antibody

Pre-made anti-PDCD7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PDCD7/PDCD7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2647-Ab-1/ GM-Tg-hg-IP2647-Ab-2Anti-Human PDCD7 monoclonal antibodyHuman
GM-Tg-rg-IP2647-Ab-1/ GM-Tg-rg-IP2647-Ab-2Anti-Rat PDCD7 monoclonal antibodyRat
GM-Tg-mg-IP2647-Ab-1/ GM-Tg-mg-IP2647-Ab-2Anti-Mouse PDCD7 monoclonal antibodyMouse
GM-Tg-cynog-IP2647-Ab-1/ GM-Tg-cynog-IP2647-Ab-2Anti-Cynomolgus/ Rhesus macaque PDCD7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2647-Ab-1/ GM-Tg-felg-IP2647-Ab-2Anti-Feline PDCD7 monoclonal antibodyFeline
GM-Tg-cang-IP2647-Ab-1/ GM-Tg-cang-IP2647-Ab-2Anti-Canine PDCD7 monoclonal antibodyCanine
GM-Tg-bovg-IP2647-Ab-1/ GM-Tg-bovg-IP2647-Ab-2Anti-Bovine PDCD7 monoclonal antibodyBovine
GM-Tg-equg-IP2647-Ab-1/ GM-Tg-equg-IP2647-Ab-2Anti-Equine PDCD7 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2647-Ab-1/ GM-Tg-hg-IP2647-Ab-2; GM-Tg-rg-IP2647-Ab-1/ GM-Tg-rg-IP2647-Ab-2;
GM-Tg-mg-IP2647-Ab-1/ GM-Tg-mg-IP2647-Ab-2; GM-Tg-cynog-IP2647-Ab-1/ GM-Tg-cynog-IP2647-Ab-2;
GM-Tg-felg-IP2647-Ab-1/ GM-Tg-felg-IP2647-Ab-2; GM-Tg-cang-IP2647-Ab-1/ GM-Tg-cang-IP2647-Ab-2;
GM-Tg-bovg-IP2647-Ab-1/ GM-Tg-bovg-IP2647-Ab-2; GM-Tg-equg-IP2647-Ab-1/ GM-Tg-equg-IP2647-Ab-2
Products NameAnti-PDCD7 monoclonal antibody
Formatmab
Target NamePDCD7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PDCD7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2647-Ag-1Recombinant multi-species PDCD7/ ES18/ HES18 protein


    Target information

    Target IDGM-IP2647
    Target NamePDCD7
    Gene ID10081,50996,363082,708758,612964,101096237,784973,100053433
    Gene Symbol and Synonyms59K,ES18,HES18,PDCD7
    Uniprot AccessionQ8N8D1
    Uniprot Entry NamePDCD7_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000090470
    Target ClassificationTumor-associated antigen (TAA)

    The target: PDCD7, gene name: PDCD7, also named as ES18, HES18. This gene encodes a 59 kDa protein that is associated with the U11 small nuclear ribonucleoprotein (snRNP), which is a component of the minor U12-type spliceosome responsible for catalyzing pre-mRNA splicing of U12-type introns. [provided by RefSeq, Dec 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.